News Sentiment

FDMT sentiment intelligence

4D Molecular Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 46 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 12.31 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 38

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-5.3% over one week, +39.4% over four weeks, trend active, and near fair-value range.

Latest direct headline Negative

4D Molecular Therapeutics (NASDAQ: FDMT) insider executes 58K-share 10b5-1 sale

Market Reaction

Price moving ahead of tone

68/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -5.3% Price reacting lower
Trend fit Trend active 39.4% over four weeks
Fair value 1.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 25
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 38
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 11
Finviz 3
Moomoo 3
simplywall.st 3
Investing.com Nigeria 2
TradingView 2
GlobeNewswire 2

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 13
Balance sheet 4
Analyst action 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-46 of 46